Andere talen Zenith Capital Corp.

Aandelen

ZHCLF

CA98935N1033

Beurs gesloten - OTC Markets Andere beurzen 21:29:11 09-12-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,1000 ^USD	0,00%		-9,09%	-16,67%

01/10	Zenith Capital Corp. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 juli 2024	CI
29/08	Zenith Capital Corp. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 30 april 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2024	01/10
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2024	29/08
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt	29/08
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	05/04
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	23/12
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2023	28-09-23
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2023	29-08-23
Zenith's Bet Inhibitor ZEN-3694 Providing Significant Clinical Benefit in Patients with Aggressive Cancer Type	01-06-23
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	06-04-23
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	24-12-22
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2022	30-09-22
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt	15-09-22
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2022	15-09-22
Zenith Epigenetics Announces Initiation of Phase 2b Triple Negative Breast Cancer Clinical Trial	10-05-22
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	01-04-22
Zenith Epigenetics Provides Clinical Update	31-01-22
Zenith Epigenetics Announces Changes to Board of Directors	31-01-22
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	20-12-21
Newsoara BioPharma Co., Ltd. announced that it expects to receive $1.5 million in funding from Zenith Capital Corp.	15-11-21
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2021	31-08-21
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt	30-08-21
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in Metastatic Castration-Resistant Prostate Cancer	24-06-21
Zenith Epigenetics Announces Clinical Collaboration with Astellas	22-04-21
Zenith Capital Corp. Reports Earnings Results for the Third Quarter Ended January 31, 2021	06-04-21
Zenith Epigenetics Announces Dosing of First Mcrpc Patient with A Combination of Zen-3694 + Merck's Immune Check Point Inhibitor Keytruda	15-03-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zenith Capital Corp.

Aandelen

ZHCLF

CA98935N1033

Andere talen

Filters